Thomas Muerdter

Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes

Werner Schroth, Lydia Antoniadou, Péter Fritz et al. · Journal of Clinical Oncology · 2007 · 466 citations

Medicine, Oncology, Pharmacology +17

Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

Maria Hägg Olofsson, Takayuki Ueno, Yang Pan et al. · Clinical Cancer Research · 2007 · 154 citations · Full text

Medicine, Oncology, Pharmacology +12

First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure

Stefan Zwirner, Anan Abu Rmilah, Sabrina Klotz et al. · Cell · 2024 · 58 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients

Natalia Sutiman, Joanne Lim, Thomas Muerdter et al. · Clinical Pharmacokinetics · 2016 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Association of<i>CYP2C19</i>*<i>2</i>and associated haplotypes with lower norendoxifen concentrations in tamoxifen‐treated<scp>Asian</scp>breast cancer patients

Joanne Lim, Natalia Sutiman, Thomas Muerdter et al. · British Journal of Clinical Pharmacology · 2016 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15